CYP2D6 and Plasmodium vivax malaria: It also found that vivax malaria patients with genotype *4/*4 of CYP2D6 poor enzyme activity were prone to the failure of PQ radical treatment for vivax malaria [7], suggesting that the influence of biological factors may cause obstacles to effectively block the transmission of vivax malaria and effectively eliminate sources of malaria infection in Yunnan Province.